Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Wolf Henning Gebhardt"'
Autor:
Viral Shah, Wolf Henning Gebhardt, George Reid, Patricia S. Haehnel, Oliver Kriege, Lars Bullinger, Claudia Scholl, Anna Dolnik, Daniel Sasca, Eva-Marie Fehr, Matthias Theobald, Jakub Szybinski, Thomas Kindler, Andrea Schüler, Petra Beli, Jan B. Heidelberger
Publikováno v:
Blood. 133(21)
Neural cell adhesion molecule 1 (NCAM1; CD56) is expressed in up to 20% of acute myeloid leukemia (AML) patients. NCAM1 is widely used as a marker of minimal residual disease; however, the biological function of NCAM1 in AML remains elusive. In this
Autor:
Jakub Szybinski, Thomas Kindler, Oliver Kriege, Kerstin Kunz, Lars Bullinger, Gerge Reid, Patricia Haehnel, Eva Marie Fehr, Wolf Henning Gebhardt, Daniel Sasca, Andrea Schueler, Matthias Theobald
Publikováno v:
Blood. 126:311-311
Background Acute myeloid leukemia (AML) is a heterogeneous disease of the hematopoietic progenitor cell driven by the subsequent acquisition of genetic alterations. Approximately 20% of AML patients show strong expression of CD56 (neural cell adhesio
Autor:
Jochen Utikal, Kristian Ikenberg, Maike Reith, Wolf-Henning Gebhardt, Christoffer Gebhardt, Kathrin Tarnanidis, Nikolaus B. Wagner, Coretta Kehrel
Publikováno v:
Cancer Research. 75:805-805
The receptor for advanced glycation end-products (RAGE) is known to act as a central driver of tumorigenesis by sustaining a chronic inflammatory tumor microenvironment. Until to date, RAGE has been exclusively described as a cell surface receptor be